15.31
Syndax Pharmaceuticals Inc Aktie (SNDX) Neueste Nachrichten
Real time pattern detection on Syndax Pharmaceuticals Inc. stock2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
Why Syndax Pharmaceuticals Inc. stock is rated strong buyForecast Cut & AI Enhanced Trade Execution Alerts - newser.com
Syndax Pharmaceuticals, Inc.'s (NASDAQ:SNDX) Path To Profitability - 富途牛牛
Is Syndax Pharmaceuticals Inc. (1T3) stock considered safe havenEarnings Growth Summary & Weekly Chart Analysis and Guides - newser.com
Technical analysis overview for Syndax Pharmaceuticals Inc. stock2025 Big Picture & Technical Entry and Exit Alerts - newser.com
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Down 3.9%Here's What Happened - MarketBeat
Syndax Pharmaceuticals Inc. stock momentum explainedJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - newser.com
Heatmap analysis for Syndax Pharmaceuticals Inc. and competitors2025 EndofYear Setup & AI Driven Stock Movement Reports - newser.com
Syndax Pharmaceuticals Inc. stock trend outlook and recovery pathMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com
Evaluating Syndax Pharmaceuticals Inc. with trendline analysis2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
Order flow analysis tools used on Syndax Pharmaceuticals Inc.July 2025 Action & Pattern Based Trade Signal System - newser.com
Will Syndax Pharmaceuticals Inc. stock see insider buying2025 EndofYear Setup & Verified Chart Pattern Signals - newser.com
Published on: 2025-10-10 04:00:50 - newser.com
Menin Inhibitors Drug Market Report 2025: Price, Sales & Clinical Trials Insights 2024-2028 - GlobeNewswire Inc.
Syndax resumed with Buy at Stifel on newly launched drugs - MSN
Analyzing drawdowns of Syndax Pharmaceuticals Inc. with statistical toolsPortfolio Value Summary & Daily Volume Surge Signals - newser.com
Published on: 2025-10-09 05:04:06 - newser.com
Should you hold or exit Syndax Pharmaceuticals Inc. nowJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Syndax Pharmaceuticals (NASDAQ:SNDX) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Is Syndax Pharmaceuticals Inc 1T3 a good long term investmentValue Traps to Avoid & Small Investment Portfolio - earlytimes.in
Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer - AOL.com
Research Analysts Offer Predictions for SNDX FY2027 Earnings - MarketBeat
Will October's FDA Decision Be A Shot In The Arm For Revuforj's Expansion? - RTTNews
Measuring Syndax Pharmaceuticals Inc.’s beta against major indices2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Comparing Syndax Pharmaceuticals Inc. in custom built stock radarsProduct Launch & Real-Time Volume Analysis Alerts - newser.com
Syndax’s Revumenib Added to NCCN AML Guidelines Ahead of October 25 FDA Decision - Yahoo Finance
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
BRIEF-Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule - The Sunday Guardian
Syndax Pharmaceuticals reports inducement grants under Nasdaq Listing Rule - MarketScreener
Does Syndax Pharmaceuticals Inc. qualify in momentum factor screeningStop Loss & Daily Entry Point Trade Alerts - newser.com
Regulatory Milestone and Analyst Optimism Fuel Momentum for Syndax Pharmaceuticals - MSN
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
What analysts say about Syndax Pharmaceuticals Inc stockEarnings Revision Updates & Minimize Portfolio Damage with Warnings - earlytimes.in
When Will Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Turn A Profit? - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):